6LYC:
reference: Macrocyclic Peptide-Mediated Blockade of the CD47-SIRPalpha Interaction as a Potential Cancer Immunotherapy., Hazama D, Yin Y, Murata Y, Matsuda M, Okamoto T, Tanaka D, Terasaka N, Zhao J, Sakamoto M, Kakuchi Y, Saito Y, Kotani T, Nishimura Y, Nakagawa A, Suga H, Matozaki T, Cell Chem Biol. 2020 Sep 17;27(9):1181-1191.e7. doi:, 10.1016/j.chembiol.2020.06.008. Epub 2020 Jul 7. PMID: 32640189

This OCA Structure page
uses Jmol, developed by the Jmol Development Team (documentation).